Silencing of CCR4-NOT complex subunits affects heart structure and function.

Area of Science:

• Cardiovascular Genetics
• Molecular Biology
• Gene Regulation

Background:

• Genome-wide association studies (GWAS) identify genetic variants associated with cardiovascular traits like QT interval length.
• The CCR4-NOT complex, a conserved regulator of gene expression, includes CNOT1, a gene with variants linked to QT interval length.

Purpose of the Study:

• To investigate the functional impact of genetic variants in the CNOT1 promoter on QT interval length.
• To explore the role of CCR4-NOT complex components in cardiac development and function using cellular and in vivo models.

Main Methods:

• Analysis of CNOT1 promoter variants in a cardiac cell line using reporter assays.
• siRNA-mediated knockdown of CCR4-NOT genes in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
• Cardiac-specific knockdown of CCR4-NOT orthologs in Drosophila models.

Main Results:

• A CNOT1 promoter haplotype associated with longer QT intervals reduced reporter gene expression in cardiac cells.
• Knockdown of CNOT1 and other CCR4-NOT genes in hiPSC-CMs impaired proliferative capacity.
• In vivo knockdown of CNOT1 and CNOT7/8/Pop2 in Drosophila led to lethality or severe cardiac defects, including dilated cardiomyopathy and arrhythmias.

Conclusions:

• Genetic variants in the CNOT1 promoter may contribute to abnormal QT intervals through reduced CNOT1 expression.
• The CCR4-NOT complex is essential for cardiomyocyte proliferation, cardiac development, and overall heart function.
• This study highlights the utility of combining cell-based and in vivo models for investigating GWAS-identified disease-associated genes.